Calvert Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-175,224
Closed -$12.5M 230
2016
Q4
$12.5M Sell
175,224
-8,573
-5% -$637K 0.47% 52
2016
Q3
$14.5M Sell
183,797
-9,143
-5% -$743K 0.53% 41
2016
Q2
$16.1M Sell
192,940
-73,917
-28% -$6.56M 0.65% 37
2016
Q1
$24.5M Buy
266,857
+1,470
+0.6% +$133K 1.08% 19
2015
Q4
$26.9M Buy
265,387
+166,487
+168% +$17.3M 1.22% 20
2015
Q3
$9.71M Buy
98,900
+42,955
+77% +$4.77M 0.48% 49
2015
Q2
$6.55M Sell
55,945
-11,733
-17% -$1.28M 0.29% 87
2015
Q1
$6.64M Buy
67,678
+7,677
+13% +$780K 0.43% 80
2014
Q4
$5.66M Buy
60,001
+4,774
+9% +$494K 0.39% 85
2014
Q3
$5.88M Buy
55,227
+40,579
+277% +$3.97M 0.44% 77
2014
Q2
$1.21M Sell
14,648
-360
-2% -$28K 0.08% 158
2014
Q1
$1.06M Buy
15,008
+82
+0.5% +$6.43K 0.08% 167
2013
Q4
$1.12M Buy
14,926
+195
+1% +$13.6K 0.08% 167
2013
Q3
$926K Sell
14,731
-1,136
-7% -$67.9K 0.12% 162
2013
Q2
$813K Buy
+15,867
New +$827K 0.11% 161

Other funds holding GILD

Calvert Investment Management's GILD Position: Q1 2017 in Review

Calvert Investment Management sold out of Gilead Sciences (GILD) in Q1 2017, closing a stake of 175,224 shares — an estimated $12.5M sold.

Calvert Investment Management first reported a position in GILD in Q2 2013 and held it in 15 quarters. The position peaked at $26.9M in Q4 2015. 1,524 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

  • Calvert Investment Management reported no remaining Gilead Sciences position as of Q1 2017 after selling out during the quarter.
  • Calvert Investment Management sold 175,224 Gilead Sciences shares in Q1 2017, an estimated $12.5M.
  • Calvert Investment Management first reported a position in Gilead Sciences in Q2 2013 and held it in 15 quarters.
  • Calvert Investment Management's Gilead Sciences position peaked at $26.9M in Q4 2015.
  • 1,524 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on Calvert Investment Management's 13F filing for Q1 2017.